PEDIATRICS Vol. 115 No. 4 April 2005, pp. 1073 (doi:10.1542/peds.2005-0197)
COMMENTARY |
Primary Hyperparathyroidism in Pediatric Patients: Clear-Cut Differences From Adult Patients
Department of Pediatrics
University of Tennessee Health Science Center
Memphis, TN 38103
Unlike the situation in adults, primary hyperparathyroidism is a rare condition in childhood.1 Until newer generations of parathyroid hormone assays became available in the mid-1980s, this diagnosis was almost unknown. The newer and more specific assays permit a more secure diagnosis of this endocrine disorder during childhood13 and are of particular value in defining those children with genetic forms of hyperparathyroidism with which >1 sibling may be affected.
In this issue of Pediatrics, Kollars et al2 describe 52 patients from a single institution (the Mayo Clinic) who underwent parathyroid gland resection from 1970 to 2000. Two other recent single-center reports, with 11 and 17 patients, respectively,1,3 describe similar findings but were not published in the pediatric literature. Together these 3 reports encompass 80 patients and define a pattern for the diagnosis and therapy of these children.13 Most pediatric patients with primary hyperparathyroidism are older adolescents, usually >16 years old. Slightly more females than males have been diagnosed. Hypercalcemia was evident in >85% of the patients. Testing of serum calcium and parathyroid hormone was performed in response to nonspecific gastrointestinal symptoms, renal colic, or musculoskeletal or neurologic symptoms. All series noted a delay of months to years before final diagnosis with end-organ involvement (nephrocalcinosis, nephrolithiasis, acute pancreatitis, or bone involvement), a frequent finding at diagnosis. Approximately two thirds of these children have a single adenoma; the remainder, with genetic forms of hyperparathyroidism,4 show multiple-gland hyperplasia. These conditions include multiple endocrine neoplasia (MEN) types I and II and non-MEN familial disease.
Although primary hyperparathyroidism is rare in children, the delay in diagnosis may intensify end-organ damage.
| FOOTNOTES |
|---|
Accepted Jan 28, 2005.
Reprint requests to (R.W.C.), Department of Pediatrics, University of Tennessee Health Science Center, 50 N Dunlop, Memphis, TN 38103. E-mail: rchesney{at}utmem.edu
No conflict of interest declared.
| REFERENCES |
|---|
|
|
|---|
- Lawson ML, Miller SF, Ellis G, Filler RM, Kooh SW. Primary hyperparathyroidism in a paediatric hospital.
QJM. 1996;89
:921
932
[Abstract/Free Full Text] - Kollars J, Zarroug AE, van Heerden J, et al. Primary hyperparathyroidism in pediatric patients.
Pediatrics. 2005;115
:974
980
[Abstract/Free Full Text] - Hsu SC, Levine MA. Primary hyperparathyroidism in children and adolescents: the Johns Hopkins Childrens Center experience 19842001. J Bone Miner Res. 2002;17(suppl 2) :N44N50
- Bastepe M, Juppner H, Thakker RV. Parathyroid disorders. In: Pediatric Bone. San Diego, CA: Elsevier Science; 2003:485508
PEDIATRICS (ISSN 1098-4275). ©2005 by the American Academy of Pediatrics
This article has been cited by other articles:
![]() |
P. Krishnamoorthy, S. Alyaarubi, S. Abish, M. Gale, P. Albuquerque, and N. Jabado Primary Hyperparathyroidism Mimicking Vaso-occlusive Crises in Sickle Cell Disease Pediatrics, August 1, 2006; 118(2): e537 - e539. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





